본문 바로가기
KERD
논문KCI 등재

Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류화학

초록

Actin-binding LIM protein 1 (ABLIM1), a member of the LIM-domain protein family, mediates interactions between actin filaments and cytoplasmic targets. However, the role of ABLIM1 in osteoclast and bone metabolism has not been reported. In the present study, we investigated the role of ABLIM1 in the receptor activator of NF-B ligand (RANKL)- mediated osteoclastogenesis. ABLIM1 expression was induced by RANKL treatment and knockdown of ABLIM1 by retrovirus infection containing Ablim1-specific short hairpin RNA (shAblim1) decreased mature osteoclast formation and bone resorption activity in a RANKL-dose dependent manner. Actin-binding LIM protein 1 (ABLIM1), a member of the LIM-domain protein family, mediates interactions between actin filaments and cytoplasmic targets. However, the role of ABLIM1 in osteoclast and bone metabolism has not been reported. In the present study, we investigated the role of ABLIM1 in the receptor activator of NF-κB ligand (RANKL)- mediated osteoclastogenesis. ABLIM1 expression was induced by RANKL treatment and knockdown of ABLIM1 by retrovirus infection containing Ablim1-specific short hairpin RNA (shAblim1) decreased mature osteoclast formation and bone resorption activity in a RANKL-dose dependent manner. Coincident with the downregulated expression of osteoclast differentiation marker genes, the expression levels of c-Fos and the nuclear factor of activated T-cells cytoplasmic 1 (NFATc1), critical transcription factors of osteoclastogenesis, were also decreased in shAblim1-infected osteoclasts during RANKLmediated osteoclast differentiation. In addition, the motility of preosteoclast was reduced by ABLIM1 knockdown via modulation of the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/Akt/Rac1 signaling pathway, suggesting another regulatory mechanism of ABLIM1 in osteoclast formation. These data demonstrated that ABLIM1 is a positive regulator of RANKLmediated osteoclast formation via the modulation of the differentiation and PI3K/Akt/Rac1-dependent motility.

Abstract

Actin-binding LIM protein 1 (ABLIM1), a member of the LIM-domain protein family, mediates interactions between actin filaments and cytoplasmic targets. However, the role of ABLIM1 in osteoclast and bone metabolism has not been reported. In the present study, we investigated the role of ABLIM1 in the receptor activator of NF-κB ligand (RANKL)- mediated osteoclastogenesis. ABLIM1 expression was induced by RANKL treatment and knockdown of ABLIM1 by retrovirus infection containing Ablim1-specific short hairpin RNA (shAblim1) decreased mature osteoclast formation and bone resorption activity in a RANKL-dose dependent manner. Coincident with the downregulated expression of osteoclast differentiation marker genes, the expression levels of c-Fos and the nuclear factor of activated T-cells cytoplasmic 1 (NFATc1), critical transcription factors of osteoclastogenesis, were also decreased in shAblim1-infected osteoclasts during RANKLmediated osteoclast differentiation. In addition, the motility of preosteoclast was reduced by ABLIM1 knockdown via modulation of the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/Akt/Rac1 signaling pathway, suggesting another regulatory mechanism of ABLIM1 in osteoclast formation. These data demonstrated that ABLIM1 is a positive regulator of RANKLmediated osteoclast formation via the modulation of the differentiation and PI3K/Akt/Rac1-dependent motility.

참고문헌 (31)

  1. Walsh MC, "Osteoimmunology: interplay between the immune system and bone metabolism", Annu Rev Immunol, 24, pp.33~63 (2006)[DOI]
  2. Takayanagi H, "The role of NFAT in osteoclast formation", Ann N Y Acad Sci, 1116, pp.227~237 (2007)[DOI]
  3. Takayanagi H, "Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems", Nat Rev Immunol, 7, pp.292~304 (2007)[DOI]
  4. Kim K, "Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis", J Biol Chem, 280, pp.35209~35216 (2005)[DOI]
  5. Baroukh B, "Osteoclasts differentiate from resident precursors in an in vivo model of synchronized resorption: a temporal and spatial study in rats", Bone, 27, pp.627~634 (2000)[DOI]
  6. Roodman GD, "Advances in bone biology: the osteoclast", Endocr Rev, 17, pp.308~332 (1996)
  7. Boudot C, "Implication of the calcium sensing receptor and the Phosphoinositide 3-kinase", Akt pathway in the extracellular calcium-mediated migration of RAW 264.7 osteoclast precursor cells, 2010, pp.46, 1416~1423
  8. Kim JM, "Distinctive and selective route of PI3K", PKCalpha-PKCdelta, Mol Cell Endocrinol, pp.2016, 437[DOI]
  9. Lee NK, "Rac1 GTPase regulates osteoclast differentiation through TRANCE-induced NF-kappa B activation", Mol Cell Biochem, 281, pp.55~61 (2006)[DOI]
  10. Wang Y, "Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis", J Bone Miner Res, 23, pp.260~270 (2008)
  11. Schmeichel KL, "The LIM domain is a modular protein-binding interface", Cell, 79, pp.211~219 (1994)[DOI]
  12. Bach I, "The LIM domain: regulation by association", Mech Dev, 91, pp.5~17 (2000)[DOI]
  13. Koch BJ, "The diversification of the LIM superclass at the base of the metazoa increased subcellular complexity and promoted multicellular specialization", PLoS One, 7, pp.e33261~ (2012)[DOI]
  14. Roof DJ, "Molecular characterization of abLIM, a novel actin-binding and double zinc finger protein", J Cell Biol, 138, pp.575~588 (1997)[DOI]
  15. Barrientos T, "Two novel members of the ABLIM protein family, ABLIM-2 and -3, associate with STARS and directly bind F-actin", J Biol Chem, 282, pp.8393~8403 (2007)[DOI]
  16. Matsuda M, "abLIM3 is a novel component of adherens junctions with actin-binding activity", Eur J Cell Biol, 89, pp.807~816 (2010)[DOI]
  17. Lu C, "Normal retinal development and retinofugal projections in mice lacking the retina-specific variant of actin-binding LIM domain protein", Neuroscience, 120, pp.121~131 (2003)[DOI]
  18. Kadrmas JL, "The LIM domain: from the cytoskeleton to the nucleus", Nat Rev Mol Cell Biol, 5, pp.920~931 (2004)[DOI]
  19. Pawson T, "Assembly of cell regulatory systems through protein interaction domains", Science, 300, pp.445~452 (2003)[DOI]
  20. Zheng Q, "The diverse biofunctions of LIM domain proteins: determined by subcellular localization and protein-protein interaction", Biol Cell, 99, pp.489~502 (2007)[DOI]
  21. Muller JM, "The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus", EMBO J, 21, pp.736~748 (2002)[DOI]
  22. Chang DF, "Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors", Dev Cell, 4, pp.107~118 (2003)[DOI]
  23. Feng Y, "The LIM protein, Limd1, regulates AP-1 activation through an interaction with Traf6 to influence osteoclast development", J Biol Chem, 282, pp.39~48 (2007)[DOI]
  24. Struckhoff EC, "The actin-binding protein UNC-115 is an effector of Rac signaling during axon pathfinding in C. elegans", Development, 130, pp.693~704 (2003)[DOI]
  25. Huang Q, "Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42", Rac1 pathway, 2005, pp.62, 1167~1175
  26. Zhang LJ, "PI3K p110alpha isoform-dependent Rho GTPase Rac1 activation mediates H2S-promoted endothelial cell migration via actin cytoskeleton reorganization", PLoS One, 7, pp.e44590~ (2012)[DOI]
  27. Itzstein C, "The regulation of osteoclast function and bone resorption by small GTPases", Small GTPases, 2, pp.117~130 (2011)[DOI]
  28. Fukuda A, "Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1", J Bone Miner Res, 20, pp.2245~2253 (2005)[DOI]
  29. Oh SJ, "Cytosolic malate dehydrogenase regulates RANKL-mediated osteoclastogenesis via AMPK", c-Fos, Biochem Biophys Res Commun, pp.2016, 475[DOI]
  30. 김인영, "Tusc2", Fus1 regulates osteoclast differentiation through NF-kB and NFATc1, 2017, pp.50(9), 454~459[DOI]
  31. Ford CE, "The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells", PLoS One, 8, pp.e54362~ (2013)[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (8건)